The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

Discontinuation of weight management medications leads to weight regain and the deterioration of cardiometabolic markers within 1.7 years.

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets patients openly request help and gives doctors the tools to focus entire ...

New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...